|
| Exchange Received Time 10/08/2018 20:28:27 Exchange Disseminated Time 10/08/2018 20:28:33 Time Taken 00:00:06 | Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
This is to inform you that the Board of Glenmark Pharmaceuticals Limited (the "Company") at its meeting held today approved the transfer of the Company''s business of Active Pharmaceuticals Ingredient (API) to its wholly owned subsidiary, subject to the approval of the shareholders.
As required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the requisite information is enclosed herewith as Annexure A.
You are requested to kindly take note of the same.
|
|
|